Title |
Unrecognized clozapine-related constipation leading to fatal intra-abdominal sepsis – a case report
|
---|---|
Published in |
International Medical Case Reports Journal, September 2015
|
DOI | 10.2147/imcrj.s86716 |
Pubmed ID | |
Authors |
Vikram Oke, Frances Schmidt, Bikash Bhattarai, Md Basunia, Chidozie Agu, Amrit Kaur, Danilo Enriquez, Joseph Quist, Divya Salhan, Vijay Gayam, Prajakta Mungikar |
Abstract |
Clozapine is the preferred antipsychotic used for the treatment of resistant schizophrenia with suicidal ideation. The drug is started at a low dose and gradually increased to a target dose of 300-450 mg/day. It is well known to cause agranulocytosis and neutropenia. Several cases of fatal sepsis have been reported in neutropenic patients and emphasis is placed on monitoring for agranulocytosis; however, clozapine also causes intestinal hypomotility and constipation, which if unrecognized can lead to intestinal obstruction, bowel necrosis, and intra-abdominal sepsis. Reduced behavioral pain reactivity in schizophrenics may alter the ability to express pain, potentially leading to a delay in the presentation for medical attention. We report a case of fatal intra-abdominal sepsis secondary to an unrecognized case of clozapine-related constipation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 34 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 5 | 15% |
Student > Ph. D. Student | 3 | 9% |
Student > Bachelor | 3 | 9% |
Librarian | 2 | 6% |
Student > Doctoral Student | 2 | 6% |
Other | 10 | 29% |
Unknown | 9 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 35% |
Biochemistry, Genetics and Molecular Biology | 3 | 9% |
Psychology | 3 | 9% |
Business, Management and Accounting | 1 | 3% |
Nursing and Health Professions | 1 | 3% |
Other | 6 | 18% |
Unknown | 8 | 24% |